Prospective Surveillance and Risk Reduction of Cancer Treatment-Related Lymphedema: Systematic Review and Meta-Analysis

Oncol Nurs Forum. 2020 Sep 1;47(5):E161-E170. doi: 10.1188/20.ONF.E161-E170.

Abstract

Problem identification: Secondary lymphedema is a chronic condition that may result from cancer-related treatments. Evidence is emerging on prospective surveillance and risk reduction.

Literature search: Databases were systematically searched through April 1, 2019, for comparative studies evaluating interventions aiming to prevent lymphedema in patients with cancer.

Data evaluation: A random-effects model was used to perform meta-analysis, when appropriate.

Synthesis: A total of 26 studies (4,095 patients) were included, with 23 providing data sufficient for meta-analysis. Surveillance programs increased the likelihood of detecting lymphedema. Physiotherapy, exercise programs, and delayed exercise reduced the incidence of lymphedema.

Implications for research: Future research should standardize (a) evidence-based interventions to reduce the development of lymphedema and increase the likelihood of early detection and (b) outcome measures to build a body of evidence that leads to practice change.

Supplemental material can be found at https: //onf.ons.org/supplementary-material-systematic-review-cancer-treatment-related-lymphedema.

Keywords: cancer treatment; lymphedema; meta-analysis; systematic review.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Exercise
  • Humans
  • Lymphedema* / etiology
  • Lymphedema* / prevention & control
  • Neoplasms* / complications
  • Prospective Studies
  • Risk Reduction Behavior